Private Label ‘Smart Imitation’ Of National Brands’ Packaging Not So Wise In US OTC Drug Sector

Featured Image

HBW Insight Mentions First Insight | Private Label 'Smart Imitation' Of National Brands' Packaging Not So Wise In US OTC Drug Sector

First Insight survey with 1,267 US consumers showed 44% are more likely to try a private label product “marketed as a dupe of a high-end product.” Providers of OTC drugs as well as other medical products in US would tread on thin regulatory ice with the practice.

 Read the full article on HBW Insight.

first insight  Report  press coverage  private label  national brands  press  hbw insight  otc

Looking for more info? Complete the form below.